L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Impacto de las nuevas guías estadounidense y británica en el manejo y el tratamiento de las dislipemias en una población laboral española
Carlos Brotons,Eva Calvo-Bonacho,Irene Moral,María Teresa García-Margallo,María Victoria Cortés-Arcas,Mireia Puig,Gastón Vázquez-Pirillo,Luis M. Ruilope +7 more
TL;DR: La nuevas recomendaciones supondrian identificar a mas pacientes de alto riesgo y tratar con hipolipemiantes a mas poblacion que con las recomENDaciones europeas, lo that aumentaria los costes.
Journal ArticleDOI
Association between physical activity and cardiovascular risk factors: Dose and sex matter.
Alejandro Santos-Lozano,Alberto Torres Barrán,Pablo Fernández-Navarro,Pedro L. Valenzuela,Adrián Castillo-García,Luis M. Ruilope,David Ríos Insua,Jose M. Ordovas,Victoria Ley,Alejandro Lucia +9 more
TL;DR: In this paper, the association between different levels of physical activity (PA) and major cardiovascular disease (CVD) risk factors in adult people, as well as sex-specific differences was studied.
Journal ArticleDOI
Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
Gerasimos Filippatos,Stefan D. Anker,Bertram Pitt,Peter Rossing,Amer Joseph,Peter Kolkhof,Marc Lambelet,Robert Lawatscheck,George L. Bakris,Luis M. Ruilope,Rajiv Agarwal +10 more
TL;DR: In patients with Type 2 diabetes (T2D), risks of cardiovascular mortality and heart failure increase with decreasing kidney function (estimated glomerular filtration rate [eGFR]) and increasing albuminuria (urine albumin-to-creatinine ratio [UACR]). Finerenone, a selective, nonsteroidal mineralocorticoid receptor antagonist, improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and T2D in FIDELITY as discussed by the authors .
Journal ArticleDOI
Antihypertensive effectiveness of lercanidipine administered using an electronic pillbox compared with usual care in a cohort of mild-to-moderately hypertensive patients: the ELECTRA study
TL;DR: Whether the use of an electronic pillbox device (medical event monitoring system [MEMS]) could improve antihypertensive effectiveness of lercanidipine in a large group of hypertensive patients treated for 12 weeks is assessed.
Journal ArticleDOI
Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements
TL;DR: There are good reasons to use HBPM systematically in patients with CKD during long-term follow-up, and even if office BP is considered normal, it is still highly desirable to obtain out-of-office data.